Alkami Technology heads into the post-earnings week with its most interesting tension sitting not in the options market or the lending pool, but in the gap between a heavyweight backer doubling down and a short base that is only now beginning to acknowledge the signal.
The ownership story is the lead here. General Atlantic — already the largest shareholder at roughly 18% of shares — spent three weeks in May buying aggressively into weakness, accumulating nearly 3.5 million shares across five sessions at prices between $16.49 and $16.87, for a combined outlay just shy of $60 million. That cluster of purchases carried a trade significance score of 3, the highest in the recent insider log. Against that backdrop, the cluster of smaller executive sells in early June — the CEO, CFO, and Chief Legal Officer each trimming modest lots at $18.95 — reads as routine compensation-related activity rather than a directional signal. The net 90-day insider position is a purchase of roughly 6.6 million shares worth over $113 million, almost entirely driven by General Atlantic's conviction.
Short sellers have been moving in the same direction, though more slowly. Short interest has fallen roughly 9.4% over the past week to 7.4% of the free float — down from around 8.9% a month ago and near its lowest point of the recent range. The borrow market is relaxed: availability runs at 102%, meaning roughly one share remains lendable for every share already borrowed, and cost to borrow is a negligible 0.9%. The ORTEX short score of 69.7 has been drifting lower through July, pulling back from readings above 70.8 seen as recently as July 17. Positioning looks like measured short covering rather than a panic unwind.
Options traders have shifted noticeably less bearish than their recent habit. The put/call ratio has dropped to 2.16, more than 1.3 standard deviations below its 20-day mean of 3.01 — a meaningful swing given that the ratio had been running in the 3.5–3.7 range through the first two weeks of July. The 52-week low on the PCR is 0.05, so this is hardly an aggressive bullish tilt, but the directional move is clear: options positioning has become meaningfully less defensive in the past ten days.
The Street is cautiously constructive but has been cutting targets for months. JP Morgan maintained its Overweight rating in late June while trimming the target from $20 to $19 — the third time the firm has lowered its target this year after cuts from $38 to $22 in February. Citizens and Needham also held positive ratings through their February revisions while taking targets sharply lower. The mean price target of $21.71 sits about 19% above the current price of $18.17, a reasonable implied upside on paper, though the direction of travel on targets has been consistently downward. The bull case centres on digital banking adoption — Alkami added 595K new users in Q1 with revenue up 29% year-on-year — while bears point to client concentration risk and rising competitive pressure from larger financial software platforms. The forward EPS year-on-year improvement factor scores in the 86th percentile, a genuine growth signal, though the EPS surprise rank of just 14 suggests the company has struggled to beat estimates consistently. Peer QTWO gained 7.4% on the week versus ALKT's 4.4%, while NCNO added 7.1% — both slightly outpacing ALKT despite the General Atlantic tailwind.
Earnings, not next quarter's but this quarter's, are the immediate watchpoint. The event log shows a Q2 result announced July 14 and delivered July 29 — today — making the next few sessions the first real price-discovery moment since that print, and how short sellers and options traders respond to whatever Alkami reported will clarify whether the covering trend has further to run.
See the live data behind this article on ORTEX.
Open ALKT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
